Infertility Expert in Miami | Kendall | South Miami | Miami Beach


SERONO Laboratories, Inc.: Principal Investigator - A phase III, prospective, randomized, assessor blind, multicenter, comparative trial of a new formulation of r-FSH versus Fertinex and Gonal-F in oligoanovulatory infertile women undergoing ovulation induction. Initiated 4/26/2001. Completed.

FERRING Pharmaceutical, Inc.: Principal Investigator - A randomized, comparative, 3-arm, parallel group, open label, multicenter study of the efficacy and safety of purified human FSH (hFSH) SC and Repronex SC when combined in continuous or sequential dose ratios in female patients 18-33 years of age, undergoing in-vitro fertilization (IVF). Initiated 12/1/2000. Completed.

SERONO Laboratories, Inc.: Sub-Investigator - A phase III, multinational, randomized, assessor-blind study to compare the safety and efficacy of a new formulation of recombinant human FSH (s-FSH) versus Fertinex versus Gonal-F in stimulating multiple follicular development prior to ART in patients pretreated with GnRH agonist. Initiated 8/1/2000. Completed.

Invited Articles: JACOBS MH: Hysteroscopy: A New Application of Old Technology – An Aid to Improvement in Gynecological Diagnosis. Women’s Wellness Newspaper 1 (4): 13-15, 1987

JACOBS MH: Prediction of Ovulation. Infertil Reprod Med Clin N Am, 2 (2): 287-306, 1991
| Follow me